ABBV vs CVS
By Alex · Tickerpine
AbbVie Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CVS |
|---|---|---|
| Price | $265.79 | $92.90 |
| Market cap | $469.68B | $118.82B |
| P/E ratio | 74.7 | 24.8 |
| ROE | — | 6.21% |
| Profit margin | 9.80% | 1.18% |
| Revenue growth | 10.20% | 7.10% |
| Dividend yield | 2.62% | 2.86% |
| Beta | 0.28 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CVS in plain English
- ABBV is the bigger company — about 4.0× the market cap of CVS.
- CVS is cheaper on earnings (P/E 24.8 vs 74.7).
- ABBV is growing revenue faster (10% vs 7%).
- CVS has the higher dividend yield (2.86% vs 2.62%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.